BioCentury
ARTICLE | Clinical News

HAP Markers: Began trial

February 26, 2001 8:00 AM UTC

Genaissance Pharmaceuticals Inc. (GNSC), New Haven, Conn. Product: HAP Markers Business: Pharmacogenetics Therapeutic category: Test Target: Genes associated with individual drug response Description...